Occidental Petroleum Corporation vs Tilray Brands Inc — how do they compare? Occidental Petroleum Corporation trades at $57.8 (market cap $56.20B), while Tilray Brands Inc trades at $4.19 (market cap $524.07M). The key difference: Occidental Petroleum Corporation is far larger — about 107.2× Tilray Brands Inc's market cap, and Occidental Petroleum Corporation pays a 1.84% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| OXY | TLRY | |
|---|---|---|
Market Cap | $56.20B | $524.07M |
Sector | Energy | Health |
52-Week High | $66.24 | $21.00 |
52-Week Low | $38.92 | $4.23 |
Enterprise Value | $77.28B | $621.22M |
Dividend Yield | 1.84% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TLRY trades at $4.23, down 1.63% on the day, with a bearish technical signal and negative earnings trends. The company reported a net loss of $2.19 billion in 2025 despite revenue growth to $821.31 million, reflecting deep profitability challenges. Analysts show cautious sentiment with 65% hold ratings, while recent news highlights expansion in medical cannabis and beverage segments amid ongoing regulatory uncertainty.
The outlook remains challenged by persistent losses and high debt-to-asset ratio of 12.25, though low P/S and P/B ratios suggest undervaluation. Key risks include profitability execution and federal cannabis policy shifts, while potential catalysts lie in international expansion and cost management improvements.
Trailing returns across standard periods
Latest headlines on both assets
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →